Stay updated on Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial
Sign up to get notified when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.

Latest updates to the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record history adds a new Revision: v3.6.6 entry and removes the previous Revision: v3.6.5 entry.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe study history now shows a new revision entry (v3.6.5) added to the record and the previous revision (v3.6.4) removed, updating the historical log to reflect the latest revision.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry (v3.6.4) is added to the study record history. The previous revision (v3.6.3) is removed, signaling an update to the record.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the study's history. The prior revision entry v3.6.2 was removed from the current change set.SummaryDifference0.1%

- Check73 days agoChange DetectedThe record history page now displays a revision tag of v3.6.2, replacing the previous v3.6.0. This indicates a platform-side update to the page rendering without changes to the underlying study data.SummaryDifference0.1%

- Check87 days agoChange DetectedThe history now shows that the study is no longer recruiting participants, indicating recruitment has ceased. The revision tag was updated to v3.6.0, replacing the previous v3.5.5 entry in the version history.SummaryDifference0.3%

Stay in the know with updates to Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.